Dr. Gregory J. Litton, M.D.
Medical Oncology (Medical Oncology Physician)
5131 Cottonwood St, L-2
Murray, UT 84107
Who else practices at this address →
Salt Lake County includes primary care (36% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Washington School of Medicine (1983)
- Years since graduation
- 43
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 363
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1983Medical school: University of Washington School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
UT license 176520-1205 -
Hematology & Oncology Physician
UT license 176520-1205
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Intermountain Medical Center Murray, UT
- Mountain View Hospital Idaho Falls, ID
- Eastern Idaho Regional Medical Center Idaho Falls, ID
- Bingham Memorial Hospital Blackfoot, ID
- Teton Valley Hospital Driggs, ID
Medical groups
- Utah Cancer Specialists PC (49 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 363
- Services billed
- 61,191
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 6,480 | 16 |
| Injection, dexamethasone sodium phosphate, 1 mg | 755 | 25 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 536 | 184 |
| Blood test, comprehensive group of blood chemicals | 397 | 143 |
| Established patient office or other outpatient visit, 30-39 minutes | 368 | 185 |
| Injection of drug or substance under skin or into muscle | 213 | 48 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 185 | 32 |
| Established patient office or other outpatient visit, 20-29 minutes | 131 | 91 |
| Administration of chemotherapy into vein, 1 hour or less | 123 | 36 |
| Measurement of immunoglobulin light chains | 104 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Murray, UT | 95 |
| Tamoxifen Citrate Other prescribers in Murray, UT | 65 |
| Imbruvica (ibrutinib) | 51 |
| Prochlorperazine Maleate Other prescribers in Murray, UT | 41 |
| Revlimid (lenalidomide) | 35 |
| Dexamethasone Other prescribers in Murray, UT | 35 |
| Ondansetron Hcl Other prescribers in Murray, UT | 33 |
| Acyclovir Other prescribers in Murray, UT | 32 |
| Letrozole Other prescribers in Murray, UT | 31 |
| Alendronate Sodium Other prescribers in Murray, UT | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 27 companies reported 43 payments worth $1,800 in total to this clinician.
| Geron Corporation | $822 |
|---|---|
| Aveo Pharmaceuticals, Inc. | $99.00 |
| AstraZeneca Pharmaceuticals LP | $87.97 |
| Daiichi Sankyo Inc. | $74.38 |
| Incyte Corporation | $64.40 |
| Merck Sharp & Dohme LLC | $57.46 |
| E.r. Squibb & Sons, L.l.c. | $56.52 |
| Novartis Pharmaceuticals Corporation | $50.78 |
| Food and Beverage | $921 |
|---|---|
| Consulting Fee | $780 |
| Education | $99.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Geron Corporation Sep 5, 2025 | Consulting Fee RYTELO · MYELODYSPLASTIC SYNDROME | $780 |
| Aveo Pharmaceuticals, Inc. Feb 3, 2025 | Education FOTIVDA · Oncology · in-kind | $99.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.